Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Hereditary Spastic Paraplegia - paediatric v1.68 RINT1 Zornitza Stark Marked gene: RINT1 as ready
Hereditary Spastic Paraplegia - paediatric v1.68 RINT1 Zornitza Stark Gene: rint1 has been classified as Amber List (Moderate Evidence).
Hereditary Spastic Paraplegia - paediatric v1.68 RINT1 Zornitza Stark Phenotypes for gene: RINT1 were changed from Hereditary spastic paraplegia, MONDO:0019064, RINT1-related to Infantile liver failure syndrome 3, MIM# 618641; Hereditary spastic paraplegia, MONDO:0019064, RINT1-related
Hereditary Spastic Paraplegia - paediatric v1.67 RINT1 Zornitza Stark Classified gene: RINT1 as Amber List (moderate evidence)
Hereditary Spastic Paraplegia - paediatric v1.67 RINT1 Zornitza Stark Gene: rint1 has been classified as Amber List (Moderate Evidence).
Hereditary Spastic Paraplegia - paediatric v1.66 RINT1 Chern Lim gene: RINT1 was added
gene: RINT1 was added to Hereditary Spastic Paraplegia - paediatric. Sources: Literature
Mode of inheritance for gene: RINT1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: RINT1 were set to 37463447
Phenotypes for gene: RINT1 were set to Hereditary spastic paraplegia, MONDO:0019064, RINT1-related
Review for gene: RINT1 was set to AMBER
gene: RINT1 was marked as current diagnostic
Added comment: PMID: 37463447
- 3 individuals from 2 unrelated families with biallelic LoF variants - hom canonical spice variant in 1 family, chet stopgain+canonical splice variants in another family.
- Affected individuals presented with early onset spastic paraplegia, ataxia, optic nerve hypoplasia, and dysmorphic features, broadening the previously described phenotype.
- One of the individual died at 14 months due to acute liver failure, probably before the development of a neurological phenotype. The episodic liver dysfunction two other patients was very similar to that previously reported in PMID: 31204009.
- RNA studies showed the splice variants result in aberrant splicing. Other functional and lipidomic analyses supportive of pathogenicity.
Sources: Literature